(Total Views: 48)
Posted On: 04/26/2017 9:16:22 AM
Post# of 72749

$ENTB's Chairman Discusses its Progress With Small Molecule Immunotherapies
https://finance.yahoo.com/news/entest-biomedi...00276.html
https://finance.yahoo.com/news/entest-biomedi...00276.html


